pith. sign in

arxiv: 2606.29883 · v1 · pith:6PEIOHNJnew · submitted 2026-06-29 · 💻 cs.CV

Building artificial intelligence virtual tissue (AIVT) for tissue state representation, feature prediction, and dynamic simulation

Qiqi Lu , Qianjin Feng , Shaoqun Zeng , Shenghua Cheng This is my paper

Pith reviewed 2026-06-30 06:26 UTC · model grok-4.3

classification 💻 cs.CV
keywords artificial intelligencevirtual tissuetissue modelingspatial multimodal datatissue dynamicsfeature predictionAI frameworkdisease modeling
0
0 comments X

The pith

An AI framework called AIVT learns unified, spatially resolved representations of tissue states from multimodal data to represent tissues, predict features, and simulate dynamics.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper proposes AIVT as an AI framework grounded in spatial multimodal data for modeling tissues in health and disease. It is built to learn representations that are unified, spatially resolved, and dynamically manipulatable. These representations support tissue state analysis, prediction of molecular and morphological features, and simulation of spatiotemporal tissue changes. A sympathetic reader would care because the work starts from the position that standard computational models cannot handle the organized, multiscale nature of real tissues.

Core claim

AIVT is an AI framework grounded in spatial multimodal data for modeling tissues in health and disease. It learns unified, spatially resolved, and dynamically manipulatable representations of tissue state, enabling tissue state representation and analysis, molecular and morphological feature prediction, and simulation of spatiotemporal tissue dynamics.

What carries the argument

AIVT, the AI framework that learns unified, spatially resolved, and dynamically manipulatable representations of tissue state from spatial multimodal data.

If this is right

  • Tissue states can be represented and analyzed through the learned unified representations.
  • Molecular and morphological features can be predicted from the representations.
  • Spatiotemporal tissue dynamics can be simulated by manipulating the representations.
  • The framework supports AI-driven modeling of tissues in both health and disease.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The approach would require substantial volumes of aligned spatial multimodal data to train the representations effectively.
  • If the dynamic manipulability holds, the same framework could be used to test the effects of hypothetical perturbations on virtual tissue models.
  • Integration with existing spatial imaging platforms could allow the representations to be updated as new data arrive.

Load-bearing premise

Conventional computational modeling approaches cannot capture the complexity of tissues as spatially organized, multiscale biological systems, while AI can overcome this by learning from spatial multimodal data.

What would settle it

Train the AIVT framework on available spatial multimodal tissue datasets and then test whether it produces accurate feature predictions or dynamics simulations on held-out tissue samples that differ in scale or disease state; consistent failure to match or exceed conventional models on these tasks would falsify the central claim.

read the original abstract

Modeling tissue states and their transitions is essential for understanding tissue homeostasis in health and pathological remodeling in disease. However, conventional computational modeling approaches are inadequate to capture the complexity of tissues as spatially organized, multiscale biological systems. Artificial intelligence (AI) has shown a remarkable ability for representing intricate systems, creating new opportunities to characterize tissue states and their transitions. Here, we propose the concept of AI virtual tissue (AIVT), an AI framework grounded in spatial multimodal data for modeling tissues in health and disease. AIVT is designed to learn unified, spatially resolved, and dynamically manipulatable representations of tissue state, enabling tissue state representation and analysis, molecular and morphological feature prediction, and simulation of spatiotemporal tissue dynamics. We outline the fundamental assumptions, core capabilities, architectural components, as well as data and algorithm foundations of AIVT as a framework for AI-driven tissue modeling.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript proposes the concept of AI virtual tissue (AIVT), an AI framework grounded in spatial multimodal data for modeling tissues in health and disease. AIVT is designed to learn unified, spatially resolved, and dynamically manipulatable representations of tissue state, enabling tissue state representation and analysis, molecular and morphological feature prediction, and simulation of spatiotemporal tissue dynamics. The paper outlines the fundamental assumptions, core capabilities, architectural components, as well as data and algorithm foundations of AIVT.

Significance. If the proposed AIVT framework were implemented with supporting validation, it could offer a new approach to tissue modeling by leveraging AI to integrate complex spatial multimodal data, potentially addressing limitations of conventional computational methods in capturing multiscale biological systems. The manuscript presents no machine-checked proofs, reproducible code, parameter-free derivations, or falsifiable predictions, as it remains a conceptual outline without empirical components.

major comments (2)
  1. [Abstract] Abstract: The central design claim states that AIVT 'is designed to learn unified, spatially resolved, and dynamically manipulatable representations of tissue state, enabling tissue state representation and analysis, molecular and morphological feature prediction, and simulation of spatiotemporal tissue dynamics,' yet the manuscript provides no algorithms, derivations, data examples, or validation experiments to demonstrate feasibility of these capabilities; this is load-bearing for the proposal's core assertion.
  2. [Core capabilities and architectural components] Section outlining core capabilities and architectural components: The capabilities are presented as design goals without addressing how the architectural components would specifically implement dynamic manipulation or handle challenges such as data sparsity, scale mismatches, or integration of multimodal inputs, leaving the transition from assumptions to enabled functions unsubstantiated.
minor comments (2)
  1. [Motivation] The motivation section could include concrete examples of where conventional modeling fails on specific tissue datasets to strengthen the rationale for the AI approach.
  2. Notation for 'unified representations' and 'spatiotemporal dynamics' should be defined more precisely when first introduced to aid clarity for readers in computational biology.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their detailed review of our conceptual manuscript on the AIVT framework. The paper is explicitly positioned as a high-level outline of assumptions, capabilities, and foundations rather than an implemented system with empirical validation. We address the major comments point by point below.

read point-by-point responses

  1. Referee: [Abstract] Abstract: The central design claim states that AIVT 'is designed to learn unified, spatially resolved, and dynamically manipulatable representations of tissue state, enabling tissue state representation and analysis, molecular and morphological feature prediction, and simulation of spatiotemporal tissue dynamics,' yet the manuscript provides no algorithms, derivations, data examples, or validation experiments to demonstrate feasibility of these capabilities; this is load-bearing for the proposal's core assertion.

    Authors: The manuscript is a conceptual framework proposal, not an empirical study. The abstract describes the intended design goals of AIVT as derived from the outlined assumptions and data/algorithm foundations. No claim is made that the capabilities have been implemented or validated in this work; such elements would belong to follow-on papers. This scope is consistent with other foundational conceptual papers in computational biology and AI for science. revision: no

  2. Referee: [Core capabilities and architectural components] Section outlining core capabilities and architectural components: The capabilities are presented as design goals without addressing how the architectural components would specifically implement dynamic manipulation or handle challenges such as data sparsity, scale mismatches, or integration of multimodal inputs, leaving the transition from assumptions to enabled functions unsubstantiated.

    Authors: The paper deliberately remains at the framework level, specifying high-level architectural components and their mapping to capabilities without prescribing particular algorithmic solutions. Concrete handling of issues such as data sparsity or multimodal integration would depend on specific model choices and is therefore not detailed here. The transition from assumptions to functions is supported at the conceptual level by the described spatial multimodal data foundations and AI representation learning principles. revision: no

Circularity Check

0 steps flagged

No significant circularity

full rationale

The paper is a high-level conceptual proposal for the AIVT framework. It contains no equations, derivations, fitted parameters, or mathematical claims that could reduce to their own inputs. The abstract and description present design motivations, core capabilities, and architectural outlines without any self-referential steps, self-citation load-bearing arguments, or renamings of known results. The derivation chain is empty by construction, making the manuscript self-contained as a non-quantitative outline.

Axiom & Free-Parameter Ledger

0 free parameters · 2 axioms · 1 invented entities

The proposal rests on domain assumptions about the limits of existing models and the power of AI, plus the introduction of a new named entity (AIVT) without implementation or external validation.

axioms (2)
  • domain assumption AI has shown a remarkable ability for representing intricate systems
    Invoked in the abstract as the basis for creating new opportunities in tissue modeling.
  • domain assumption Conventional computational modeling approaches are inadequate to capture the complexity of tissues as spatially organized, multiscale biological systems
    Core premise stated in the abstract to justify the need for AIVT.
invented entities (1)
  • AIVT (AI virtual tissue) no independent evidence
    purpose: Unified AI framework for tissue state representation, prediction, and dynamic simulation
    Newly coined concept introduced in the paper with no implementation, code, or independent evidence provided.

pith-pipeline@v0.9.1-grok · 5691 in / 1398 out tokens · 28435 ms · 2026-06-30T06:26:01.349264+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

110 extracted references · 10 canonical work pages · 1 internal anchor

  1. [1]

    & Wickström, S

    Mao, Y. & Wickström, S. A. Mec hanical state transitions in the regulation of tissue form and function. Nat Rev Mol Cell Biol 25, 654–670 (2024)

    2024

  2. [2]

    Sherwood, E. R. & Toliver-Kinsky, T. Mechanisms of the inflammatory response. Best Practice & Research Clinical Anaesthesiology 18, 385–405 (2004)

    2004

  3. [3]

    De Visser, K. E. & Joyce, J. A. The evolvi ng tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374–403 (2023)

    2023

  4. [4]

    & Lundeberg, J

    Lázár, E. & Lundeberg, J. Spatial architecture of development and disease. Nat Rev Genet 27, 118– 136 (2026)

    2026

  5. [5]

    & Fleck, C

    Pleyer, J. & Fleck, C. Agent -based models in cellular systems. Front. Phys. 10, 968409 (2023)

    2023

  6. [6]

    & Macklin, P

    Metzcar, J., Wang, Y., Heiland, R. & Macklin, P. A Review of Cell-Based Computational Modeling in Cancer Biology. JCO Clin Cancer Inform 3, 1–13 (2019)

    2019

  7. [7]

    Johnson, J. A. I. et al. Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories. Cell 188, 4711–4733 (2025)

    2025

  8. [8]

    & Edelstein-Keshet, L

    Buttenschön, A. & Edelstein-Keshet, L. Bridging fr om single to collective cell migration: A review of models and links to experiments. PLoS Comput Biol 16, e1008411 (2020)

    2020

  9. [9]

    & Iber, D

    Runser, S., Vetter, R. & Iber, D. SimuCell3D: three-dimensional simulation of tissue mechanics with cell polarization. Nat Comput Sci 4, 299–309 (2024)

    2024

  10. [10]

    Liu, L. et al. Spatiotemporal omics for biology and medicine. Cell 187, 4488–4519 (2024)

    2024

  11. [11]

    Chen, M. et al. Multimodal whole slide image processing pipeline for quantitative mapping of tissue architecture and tissue microenvironment. npj Imaging 3, 26 (2025)

    2025

  12. [12]

    Liu, J. T. C. et al. Harnessing non-destructive 3D pathology. Nat Biomed Eng 5, 203–218 (2021)

    2021

  13. [13]

    Bishop, K. W. et al. An end-to-end workflow for nondestructive 3D pathology. Nat Protoc 19, 1122– 1148 (2024)

    2024

  14. [14]

    Withers, P. J. et al. X-ray computed tomography. Nat Rev Methods Primers 1, 18 (2021)

    2021

  15. [15]

    & K illingsworth, M

    Cohen Hyams, T., Mam, K. & K illingsworth, M. C. Scanning electr on microscopy as a new tool for diagnostic pathology and cell biology. Micron 130, 102797 (2020)

    2020

  16. [16]

    Vickovic, S. et al. High-definition spatial transcripto mics for in situ tissue profiling. Nat Methods 16, 987–990 (2019)

    2019

  17. [17]

    Oliveira, M. F. D. et al. High-definition spatial transcriptomic pr ofiling of immune cell populations in colorectal cancer. Nat Genet 57, 1512–1523 (2025)

    2025

  18. [18]

    Zhao, Y. et al. Stereo-seq V2: Spatial mapping of total RNA on FFPE sections with high resolution. Cell 188, 1–18 (2025)

    2025

  19. [19]

    Chen, A. et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball- patterned arrays. Cell 185, 1777–1792 (2022)

    2022

  20. [20]

    Hickey, J. W. et al. Spatial mapping of prot ein composition and tissue organization: a primer for multiplexed antibody-based imaging. Nat Methods 19, 284–295 (2022)

    2022

  21. [21]

    Rosenberger, F. A. et al. Deep Visual Proteomics maps proteotox icity in a genetic liver disease. Nature 642, 484–491 (2025)

    2025

  22. [22]

    Hu, B. et al. High-resolution spatially resolved proteomics of complex tissues based on microfluidics and transfer learning. Cell 188, 734–748 (2025)

    2025

  23. [23]

    Liu, C. et al. Multitask benchmarking of single-cell multimodal omics integration methods. Nat Methods 22, 2449–2460 (2025)

    2025

  24. [24]

    Ståhl, P. L. et al. Visualization and analysis of gene expr ession in tissue sections by spatial transcriptomics. Science 353, 78–82 (2016)

    2016

  25. [25]

    E., Tsai, A

    Henze, D. E., Tsai, A. P., Wyss-Coray, T. & Q uake, S. R. Simultaneous spatial transcriptomics and morphology profiling as tools to explore how microglia change with age. Nat Aging 6, 869–885 (2026)

    2026

  26. [26]

    Liu, Y. et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat Biotechnol 41, 1405–1409 (2023)

    2023

  27. [27]

    Guo, P. et al. Multiplexed spatial mapping of chromatin features, transcriptome and proteins in tissues. Nat Methods 22, 520–529 (2025)

    2025

  28. [28]

    Zhang, D. et al. Spatial epigenome–transcriptome co-profiling of mammalian tissues. Nature 616, 113–122 (2023)

    2023

  29. [29]

    Jiang, F. et al. Simultaneous profiling of spatial gene ex pression and chromatin accessibility during mouse brain development. Nat Methods 20, 1048–1057 (2023)

    2023

  30. [30]

    N., Fu, H., Cardilla, A., Zhou, W

    Lee, C. N., Fu, H., Cardilla, A., Zhou, W. & De ng, Y. Spatial joint prof iling of DNA methylome and transcriptome in tissues. Nature 646, 1261–1271 (2025)

    2025

  31. [31]

    Vandergrift, G. W. et al. Untargeted Spatial Metabolomics and Spatial Proteomics on the Same Tissue Section. Anal. Chem. 97, 392–400 (2025)

    2025

  32. [32]

    Vicari, M. et al. Spatial multimodal analysis of transcriptomes and metabolomes in tissues. Nat Biotechnol 42, 1046–1050 (2024)

    2024

  33. [33]

    Bunne, C. et al. How to build the virtual cell with artificial intelligence: Priorities and opportunities. Cell 187, 7045–7063 (2024)

    2024

  34. [34]

    & Guo, T

    Qian, L., Dong, Z. & Guo, T. Grow AI virtual cells: three data pillars and closed-loop learning. Cell Res 35, 319–321 (2025)

    2025

  35. [35]

    Bai, L. & Su, J. Artificial Intelligence Virtual Organoids (AIVOs). Bioactive Materials 59, 45–68 (2026)

    2026

  36. [36]

    Coleman, K., Schroeder, A. & Li, M. Un locking the power of spatial omics with AI. Nat Methods 21, 1378–1381 (2024)

    2024

  37. [37]

    & Wählby, C

    Chelebian, E., Avenel, C. & Wählby, C. Combin ing spatial transcriptomics with tissue morphology. Nat Commun 16, 4452 (2025)

    2025

  38. [38]

    Coleman, K. et al. Resolving tissue complexity by multimodal spatial omics modeling with MISO. Nat Methods 22, 530–538 (2025)

    2025

  39. [39]

    Yang, P. et al. Revealing spatial multimodal heterogeneity in tissues with SpaTrio. Cell Genomics 3, 100446 (2023)

    2023

  40. [40]

    O’Brien, L. E. Tissue Homeostasis and Non-Hom eostasis: From Cell Life Cycles to Organ States. Annu. Rev. Cell Dev. Biol. 38, 395–418 (2022)

    2022

  41. [41]

    Shen, K. et al. Spatial perturb-seq: single-cell functional genomics within intact tissue architecture. Nat Commun 17, 3018 (2026)

    2026

  42. [42]

    Long, Y. et al. Deciphering spatial domains from s patial multi-omics with SpatialGlue. Nat Methods 21, 1658–1667 (2024)

    2024

  43. [43]

    Yang, P. et al. Spatial integration of multi- omics single-cell data with SIMO. Nat Commun 16, 1265 (2025)

    2025

  44. [44]

    He, B. et al. Integrating spatial gene expression and br east tumour morphology via deep learning. Nat Biomed Eng 4, 827–834 (2020)

    2020

  45. [45]

    Almagro-Pérez, C. et al. AI-driven 3D Spatial Transcriptomics. Preprint at https://doi.org/10.48550/arXiv.2502.17761 (2025)

    work page doi:10.48550/arxiv.2502.17761 2025

  46. [46]

    Ghahremani, P. et al. Deep learning-inferred multiplex immunofluorescence for immunohistochemical image quantification. Nat Mach Intell 4, 401–412 (2022)

    2022

  47. [47]

    Li, Z. et al. AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer. Nat Med 32, 231–244 (2026)

    2026

  48. [48]

    Rivenson, Y. et al. Virtual histological staining of unlabelled tissue-autofluorescence images via deep learning. Nat Biomed Eng 3, 466–477 (2019)

    2019

  49. [49]

    Pati, P. et al. Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling. Nat Mach Intell 6, 1077–1093 (2024)

    2024

  50. [50]

    & VanRullen, R

    Devillers, B., Maytié, L. & VanRullen, R. Se mi-Supervised Multimodal Representation Learning Through a Global Workspace. IEEE Trans. Neural Netw. Learning Syst. 36, 7843–7857 (2025)

    2025

  51. [51]

    Walsh, L. A. & Quail, D. F. Decoding t he tumor microenvironment with spatial technologies. Nat Immunol 24, 1982–1993 (2023)

    1982

  52. [52]

    Rao, A., Barkley, D., França, G. S. & Yanai, I. Exploring tissue architecture using spatial transcriptomics. Nature 596, 211–220 (2021)

    2021

  53. [53]

    & Wang, L

    Liu, Y., Dai, Y. & Wang, L. Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell 44, 24–49 (2026)

    2026

  54. [54]

    & Engelhardt, B

    Jones, A., Cai, D., Li, D. & Engelhardt, B. E. Optimizing the design of spatial genomic studies. Nat Commun 15, 4987 (2024)

    2024

  55. [55]

    Yuan, M. et al. Smart spatial omics (S2-omics) optimizes region of interest selection to capture molecular heterogeneity in diverse tissues. Nat Cell Biol 27, 2225–2238 (2025)

    2025

  56. [56]

    Sharma, A. et al. From tissue architecture to clinical insi ghts: Spatial transcriptomics in solid tumor studies. Seminars in Oncology 52, 152389 (2025)

    2025

  57. [57]

    Seferbekova, Z., Lomakin, A., Yates, L. R. & Ge rstung, M. Spatial biolog y of cancer evolution. Nat Rev Genet 24, 295–313 (2023)

    2023

  58. [58]

    Gu, J. et al. Mapping multimodal phenotypes to perturbat ions in cells and tissue with CRISPRmap. Nat Biotechnol 43, 1101–1115 (2025)

    2025

  59. [59]

    L., Franklin, R

    Meizlish, M. L., Franklin, R. A., Zhou, X. & Medzhitov, R. Tissue Homeostasis and Inflammation. Annu. Rev. Immunol. 39, 557–581 (2021)

    2021

  60. [60]

    Tian, S. et al. Opportunities and challenges for ChatGPT and large language models in biomedicine and health. Briefings in Bioinformatics 25, bbad493 (2023)

    2023

  61. [61]

    Zhang, S. et al. A Multimodal Biomedical Foundation Model Trained from Fifteen Million Image–Text Pairs. NEJM AI 2, (2025)

    2025

  62. [62]

    Radford, A. et al. Learning Transferable Visual Models From Natural Language Supervision. in Proceedings of the 38th International Conference on Machine Learning vol. 139 8748–8763 (2021)

    2021

  63. [63]

    & De Melo, G

    Eslami, S., Meinel, C. & De Melo, G. PubMedCLI P: How Much Does CLIP Benefit Visual Question Answering in the Medical Domain? in Findings of the Association for Computational Linguistics: EACL 2023 1181–1193 (Association for Computational Linguistics, Dubrovnik, Croatia, 2023)

    2023

  64. [64]

    & Toutanova, K

    Devlin, J., Chang, M.-W., Lee, K. & Toutanova, K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. in Proceedings of the 2019 Conference of the North 4171–4186 (Association for Computational Linguistics, Minneapolis, Minnesota, 2019)

    2019

  65. [65]

    Huang, Z., Bianchi, F., Yuksekgonul, M., Montine, T. J. & Zou, J. A visual–language foundation model for pathology image analysis using medical Twitter. Nat Med 29, 2307–2316 (2023)

    2023

  66. [66]

    Filiot, A. et al. Scaling Self-Supervised Learning for Histopathology with Mask ed Image Modeling. Preprint at https://doi.org/10.1101/2023.07.21.23292757 (2023)

    work page doi:10.1101/2023.07.21.23292757 2023

  67. [67]

    Chen, R. J. et al. Towards a general-purpose foundation model for computational pathology. Nat Med 30, 850–862 (2024)

    2024

  68. [68]

    Wang, X. et al. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature 634, 970–978 (2024)

    2024

  69. [69]

    Xu, H. et al. A whole-slide foundation model for digital pathology from real-world data. Nature 630, 181–188 (2024)

    2024

  70. [70]

    Chen, W. et al. A visual–omics foundation model to bridge histopathology with spatial transcriptomics. Nat Methods 22, 1568–1582 (2025)

    2025

  71. [71]

    Hemker, K. et al. Towards Spatial Transcriptomics-driven Pathology Foundation Models. Preprint at https://doi.org/10.48550/arXiv.2602.14177 (2026)

    work page doi:10.48550/arxiv.2602.14177 2026

  72. [72]

    Zhao, S. et al. SToFM: a Multi-scale Foundation Model for Spatial Transcriptomics. in Proceedings of the 42nd International Conference on Machine Learning 77589–77607 (JMLR.org, Vancouver, Canada, 2025)

    2025

  73. [73]

    Cao, S. et al. stFormer: a foundation model for s patial transcriptomics. Preprint at https://doi.org/10.1101/2024.09.27.615337 (2024)

    work page doi:10.1101/2024.09.27.615337 2024

  74. [74]

    & Jin, W

    Huang, T., Liu, T., Babadi, M., Ying, R. & Jin, W. STPath: a generative foundation model for integrating spatial transcriptomics and whole-slide images. npj Digit. Med. 8, 659 (2025)

    2025

  75. [75]

    Wang, Y. et al. FmH2ST: foundation model-based spatial transcriptomics generation from histological images. Nucleic Acids Research 53, gkaf865 (2025)

    2025

  76. [76]

    & Cournède, P.-H

    Blampey, Q., Benkirane, H., Bercovici, N., A ndré, F. & Cournède, P.-H. Novae: a graph-based foundation model for spatial transcriptomics data. Nature Methods 22, 2539–2550 (2025)

    2025

  77. [77]

    Wenckstern, J. et al. AI-powered virtual tissues from spatia l proteomics for clinical diagnostics and biomedical discovery. Preprint at https://doi.org/10.48550/arXiv.2501.06039 (2025)

    work page doi:10.48550/arxiv.2501.06039 2025

  78. [78]

    Madhu, H. et al. HEIST: A Graph Foundation Model for Spatial Transcriptomics and Proteomics Data. Preprint at https://doi.org/10.48550/arXiv.2506.11152 (2025)

    work page internal anchor Pith review Pith/arXiv arXiv doi:10.48550/arxiv.2506.11152 2025

  79. [79]

    Shaban, M. et al. A Foundation Model for Spat ial Proteomics. Preprint at https://doi.org/10.48550/arXiv.2506.03373 (2025)

    work page doi:10.48550/arxiv.2506.03373 2025

  80. [80]

    & Hakonarson, H

    Tian, T., Zhang, J., Lin, X., Wei, Z. & Hakonarson, H. Dependency-aware deep generative models for multitasking analysis of spatial omics data. Nat Methods 21, 1501–1513 (2024)

    2024

Showing first 80 references.